Your browser doesn't support javascript.
loading
UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept.
Martinez-Useros, Javier; Georgiev-Hristov, Tihomir; Fernández-Aceñero, María Jesús; Borrero-Palacios, Aurea; Indacochea, Alberto; Guerrero, Santiago; Li, Weiyao; Cebrián, Arancha; Gómez Del Pulgar, Teresa; Puime-Otin, Alberto; Del Puerto-Nevado, Laura; Rodríguez-Remírez, María; Pérez, Nuria; Celdrán, Angel; Gebauer, Fátima; Garcia-Foncillas, Jesus.
Afiliación
  • Martinez-Useros J; Translational Oncology Division, OncoHealth Institute, University Hospital Fundacion Jimenez Diaz (FJD), Madrid, Spain.
  • Georgiev-Hristov T; Surgery Department, Hospital de Villalba, Collado-Villalba, Spain.
  • Fernández-Aceñero MJ; Department of Pathology, Clinico San Carlos University Hospital, C/ Profesor Martin Lagos, Madrid, Spain.
  • Borrero-Palacios A; Translational Oncology Division, OncoHealth Institute, University Hospital Fundacion Jimenez Diaz (FJD), Madrid, Spain.
  • Indacochea A; Gene Regulation, Stem Cells and Cancer Programme, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Guerrero S; Oncology and Molecular Pathology Research Group-VHIR- Vall d' Hebron Institut de Recerca-Vall d' Hebron Hospital, P/ de la Vall d'Hebron, Barcelona, Spain.
  • Li W; Gene Regulation, Stem Cells and Cancer Programme, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Cebrián A; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Gómez Del Pulgar T; Translational Oncology Division, OncoHealth Institute, University Hospital Fundacion Jimenez Diaz (FJD), Madrid, Spain.
  • Puime-Otin A; Translational Oncology Division, OncoHealth Institute, University Hospital Fundacion Jimenez Diaz (FJD), Madrid, Spain.
  • Del Puerto-Nevado L; Translational Oncology Division, OncoHealth Institute, University Hospital Fundacion Jimenez Diaz (FJD), Madrid, Spain.
  • Rodríguez-Remírez M; Department of Pathology, University Hospital Fundacion Jimenez Diaz, Madrid, Spain.
  • Pérez N; Translational Oncology Division, OncoHealth Institute, University Hospital Fundacion Jimenez Diaz (FJD), Madrid, Spain.
  • Celdrán A; Translational Oncology Division, OncoHealth Institute, University Hospital Fundacion Jimenez Diaz (FJD), Madrid, Spain.
  • Gebauer F; Department of Pathology, University Hospital Fundacion Jimenez Diaz, Madrid, Spain.
  • Garcia-Foncillas J; Hepatobiliary and Pancreatic Surgery Unit, General and Digestive Tract Surgery Department, Fundacion Jimenez Diaz University Hospital, Madrid, Spain.
PLoS One ; 12(8): e0182044, 2017.
Article en En | MEDLINE | ID: mdl-28763470

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2017 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2017 Tipo del documento: Article País de afiliación: España